BioCentury
ARTICLE | Company News

Management tracks

April 24, 2015 1:50 AM UTC

Royalty play Ligand Pharmaceuticals Inc. (NASDAQ:LGND) said CFO Nishan de Silva resigned effective May 20. Melanie Herman, Ligand's director of accounting and chief accounting officer, will be interim CFO.

Renal therapeutic company Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) named John Neylan CMO. Neylan was SVP of clinical development at Genzyme Corp. ...